Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Endonovo Therapeutics Inc ENDV

Healthcare Biotechnology
Endonovo Therapeutics, Inc. is a biotechnology company. The Company is focused on developing bioelectronic devices and cell therapies for regenerative medicine and is a commercial-stage developer of non-invasive wearable Electroceuticals therapeutic devices. The Company's portfolio of commercial and clinical-stage wearable Electroceuticals therapeutic devices addresses wound healing, pain, post... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:ENDV)

Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc

GlobeNewswire March 28, 2024

Endonovo's SofPulse® to Be Featured at Innovative Pain Management Solutions

GlobeNewswire March 4, 2024

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

GlobeNewswire December 4, 2023

Endonovo's SofPulse® Secures Taiwan FDA Approval

GlobeNewswire October 12, 2023

Endonovo's SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

GlobeNewswire August 22, 2023

Endonovo's Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

GlobeNewswire August 8, 2023

Endonovo Pending Agreement to Develop Telehealth Division

GlobeNewswire June 7, 2023

Endonovo Launches SofPulse® into the Veterans Administration

GlobeNewswire May 2, 2023

Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies

GlobeNewswire April 25, 2023
View More News ››

Opinion & Analysis (PINL:ENDV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:ENDV)

Be the first to post on this bullboard.

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ...
View More »